1. Home
  2. SRPT vs PSNY Comparison

SRPT vs PSNY Comparison

Compare SRPT & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • PSNY
  • Stock Information
  • Founded
  • SRPT 1980
  • PSNY 2017
  • Country
  • SRPT United States
  • PSNY Sweden
  • Employees
  • SRPT N/A
  • PSNY N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • PSNY Auto Manufacturing
  • Sector
  • SRPT Health Care
  • PSNY Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • PSNY Nasdaq
  • Market Cap
  • SRPT 1.9B
  • PSNY 1.9B
  • IPO Year
  • SRPT 1997
  • PSNY N/A
  • Fundamental
  • Price
  • SRPT $23.53
  • PSNY $0.86
  • Analyst Decision
  • SRPT Hold
  • PSNY Hold
  • Analyst Count
  • SRPT 31
  • PSNY 2
  • Target Price
  • SRPT $40.61
  • PSNY $1.25
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • PSNY 2.9M
  • Earning Date
  • SRPT 11-05-2025
  • PSNY 09-03-2025
  • Dividend Yield
  • SRPT N/A
  • PSNY N/A
  • EPS Growth
  • SRPT N/A
  • PSNY N/A
  • EPS
  • SRPT N/A
  • PSNY N/A
  • Revenue
  • SRPT $2,481,531,000.00
  • PSNY $2,547,619,000.00
  • Revenue This Year
  • SRPT $9.41
  • PSNY $48.90
  • Revenue Next Year
  • SRPT N/A
  • PSNY $44.64
  • P/E Ratio
  • SRPT N/A
  • PSNY N/A
  • Revenue Growth
  • SRPT 64.89
  • PSNY 24.82
  • 52 Week Low
  • SRPT $10.42
  • PSNY $0.84
  • 52 Week High
  • SRPT $138.81
  • PSNY $1.42
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 62.36
  • PSNY 34.81
  • Support Level
  • SRPT $21.93
  • PSNY $0.87
  • Resistance Level
  • SRPT $23.87
  • PSNY $0.97
  • Average True Range (ATR)
  • SRPT 1.42
  • PSNY 0.04
  • MACD
  • SRPT 0.10
  • PSNY -0.00
  • Stochastic Oscillator
  • SRPT 71.74
  • PSNY 4.01

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

Share on Social Networks: